Interparfums, Inc. (IPAR)
(Delayed Data from NSDQ)
$121.69 USD
+0.62 (0.51%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $121.49 -0.20 (-0.16%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$121.69 USD
+0.62 (0.51%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $121.49 -0.20 (-0.16%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
Zacks News
Things to Support Molson Coors' (TAP) Earnings Beat in Q4
by Zacks Equity Research
Molson Coors' (TAP) Q4 results are expected to reflect the benefits of pricing actions, the revitalization plan and the premiumization of its global portfolio.
Are Consumer Staples Stocks Lagging Inter Parfums (IPAR) This Year?
by Zacks Equity Research
Here is how Inter Parfums (IPAR) and Coca-Cola FEMSA (KOF) have performed compared to their sector so far this year.
Inter Parfums (IPAR) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Inter Parfums (IPAR) possesses solid growth attributes, which could help it handily outperform the market.
Nu Skin (NUS) Q4 Earnings Top Estimates, Sales Down Y/Y
by Zacks Equity Research
Nu Skin's (NUS) fourth-quarter 2022 results reflect lower revenues and earnings on macro headwinds, continued inflation and unfavorable currency.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Here's How Much You'd Have If You Invested $1000 in Inter Parfums a Decade Ago
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
COTY or IPAR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
COTY vs. IPAR: Which Stock Is the Better Value Option?
Why Boston Beer (SAM) is Likely to Report Earnings Beat in Q4
by Zacks Equity Research
Boston Beer's (SAM) Q4 results are likely to reflect gains from improved shipments and depletions, better pricing, and innovation, offset by a slowdown in hard seltzer and higher costs.
Beat the Market Like Zacks: NVIDIA, Boeing, Rockwell Medical in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Factors Likely to Support Coca-Cola's (KO) Earnings Beat in Q4
by Zacks Equity Research
Coca-Cola's (KO) Q4 results are expected to reflect gains form growth across markets and categories, improved price/mix and strong brand portfolio.
COTY Q2 Earnings Surpass Estimates, Sales Decrease Y/Y
by Zacks Equity Research
COTY second-quarter fiscal 2023 results reflect improved earnings on higher adjusted net income. However, sales fall year over year.
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Coty (COTY) Beats Q2 Earnings Estimates
by Zacks Equity Research
Coty (COTY) delivered earnings and revenue surprises of 46.67% and 0.29%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Take the Zacks Approach to Beat the Market: Ulta Beauty, Clorox, Similarweb in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Clorox (CLX) Q2 Earnings and Sales Beat, Stock Rises 4.2%
by Zacks Equity Research
Clorox's (CLX) Q2 results reflect gains from strong demand trends, improved pricing, cost savings and strong execution, offset by lower volume and higher commodity costs.
Estee Lauder (EL) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of 19.38% and 1.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
3 Cosmetic Stocks Likely to Top Earnings Estimates This Season
by Vrishali Bagree
Cosmetic companies gain from favorable demand and a focus on newness. The Estee Lauder Companies (EL), Coty (COTY) and Inter Parfums (IPAR) are likely to beat earnings estimates this season.
Is Inter Parfums (IPAR) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Inter Parfums (IPAR) and Coca-Cola FEMSA (KOF) have performed compared to their sector so far this year.
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
If You Invested $1000 in Inter Parfums 10 Years Ago, This Is How Much You'd Have Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Are You Looking for a Top Momentum Pick? Why Inter Parfums (IPAR) is a Great Choice
by Zacks Equity Research
Does Inter Parfums (IPAR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Best Income Stocks to Buy for January 25th
by Zacks Equity Research
IPAR, DTEGY and PCRFY made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 25, 2023.
Inter Parfums (IPAR) Posts Robust Sales Numbers for Q4 & 2022
by Zacks Equity Research
Inter Parfums' (IPAR) fourth-quarter and full-year 2022 sales gain from the company's brand strength. Management remains encouraged about its prospects in 2023.
Prudent Partnerships & Growth Pillars Aid COTY, High Costs Ail
by Zacks Equity Research
COTY is benefiting from its focus on six strategic pillars of sustainable growth. The company is on track to mitigate the impact of inflation via cost savings.
Mondelez (MDLZ) Looks Tempting on Snacking Category Strength
by Zacks Equity Research
Mondelez (MDLZ) highlights that consumers continue to put snacking as a priority, even amid inflated costs and economic headwinds. The company remains well-placed for growth.